170 related articles for article (PubMed ID: 34452055)
1. Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers.
Wi YM; Kim SH; Peck KR
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452055
[TBL] [Abstract][Full Text] [Related]
2. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study.
Assawasaksakul T; Lertussavavivat T; Sathitratanacheewin S; Oudomying N; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Avihingsanon Y; Assawasaksakul N; Buranapraditkun S; Kittanamongkolchai W
Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746461
[TBL] [Abstract][Full Text] [Related]
4. Can reactogenicity predict immunogenicity after COVID-19 vaccination?
Hwang YH; Song KH; Choi Y; Go S; Choi SJ; Jung J; Kang CK; Choe PG; Kim NJ; Park WB; Oh MD
Korean J Intern Med; 2021 Nov; 36(6):1486-1491. PubMed ID: 34038996
[TBL] [Abstract][Full Text] [Related]
5. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines.
Dutta S; Kaur R; Charan J; Bhardwaj P; Ambwani SR; Babu S; Goyal JP; Haque M
Cureus; 2022 Jan; 14(1):e21376. PubMed ID: 35198288
[TBL] [Abstract][Full Text] [Related]
8. Adverse Events Following BNT162b2 mRNA COVID-19 Vaccine Immunization among Healthcare Workers in a Tertiary Hospital in Johor, Malaysia.
Tan AY; Chang CT; Yu YK; Low YX; Razali NFM; Tey SY; Lee SWH
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455258
[TBL] [Abstract][Full Text] [Related]
9. Adverse Events Associated with BNT162b2 and AZD1222 Vaccines in the Real World: Surveillance Report in a Single Italian Vaccine Center.
Costantino M; Sellitto C; Conti V; Corbi G; Marongiu F; Genovese G; Moccia G; Capunzo M; Borrelli A; Pagliano P; Farroni M; Lombardi GM; Elberti MG; Filippelli A; De Caro F
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268499
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222.
Terpos E; Karalis V; Ntanasis-Stathopoulos I; Evangelakou Z; Gavriatopoulou M; Manola MS; Malandrakis P; Gianniou DD; Kastritis E; Trougakos IP; Dimopoulos MA
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203547
[TBL] [Abstract][Full Text] [Related]
11. Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study.
Kang YM; Lim J; Choe KW; Lee KD; Jo DH; Kim MJ; Kim JM; Kim KN
Clin Exp Vaccine Res; 2021 Sep; 10(3):282-289. PubMed ID: 34703812
[TBL] [Abstract][Full Text] [Related]
12. Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population.
Tabatabaeifar S; Vestergaard JM; Würtz ET; Hansen KK; Nielsen KJ; Schlünssen V; Kolstad HA
Vaccine X; 2023 Apr; 13():100280. PubMed ID: 36945661
[TBL] [Abstract][Full Text] [Related]
13. Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection.
Parés-Badell O; Martínez-Gómez X; Pinós L; Borras-Bermejo B; Uriona S; Otero-Romero S; Rodrigo-Pendás JÁ; Cossio-Gil Y; Agustí A; Aguilera C; Campins M
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960209
[TBL] [Abstract][Full Text] [Related]
14. Transient Autoreactive PF4 and Antiphospholipid Antibodies in COVID-19 Vaccine Recipients.
Raadsen MP; Visser C; Lavell AHA; van de Munckhof AAGA; Coutinho JM; de Maat MPM; GeurtsvanKessel CH; Amsterdam Umc Covid-S/Hcw Study Group ; Bomers MK; Haagmans BL; van Gorp ECM; Porcelijn L; Kruip MJHA
Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140254
[TBL] [Abstract][Full Text] [Related]
15. Increased adverse events following third dose of BNT162b2/Pfizer vaccine in those with previous COVID-19, but not with concurrent influenza vaccine.
Raw RK; Rees J; Chadwick DR
PLOS Glob Public Health; 2023; 3(2):e0001053. PubMed ID: 36963011
[TBL] [Abstract][Full Text] [Related]
16. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
[TBL] [Abstract][Full Text] [Related]
17. Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan.
Urakawa R; Isomura ET; Matsunaga K; Kubota K
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016244
[TBL] [Abstract][Full Text] [Related]
18. Sex and gender differences in adverse events following receipt of influenza and COVID-19 vaccination among healthcare workers.
Yin A; Wang N; Shea PJ; Rosser EN; Kuo H; Shapiro JR; Fenstermacher KZJ; Pekosz A; Rothman RE; Klein SL; Morgan R
medRxiv; 2024 Jan; ():. PubMed ID: 38318206
[TBL] [Abstract][Full Text] [Related]
19. Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review.
Amanzio M; Mitsikostas DD; Giovannelli F; Bartoli M; Cipriani GE; Brown WA
Lancet Reg Health Eur; 2022 Jan; 12():100253. PubMed ID: 34729549
[TBL] [Abstract][Full Text] [Related]
20. Adverse Effects on Work and Daily Life Interference among Healthcare Workers after the First and Second ChAdOx1 and BNT162b2 COVID-19 Vaccine Doses.
Park C; Sakong J; Jo S; Kim M; Baek K
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
